Maat Pharma (XPAR:MAAT) Other Operating Expense : €-0.59 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Maat Pharma Other Operating Expense?

Maat Pharma's Other Operating Expense for the six months ended in Dec. 2024 was €1.35 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.59 Mil.

Maat Pharma's quarterly Other Operating Expense declined from Dec. 2023 (€0.25 Mil) to Jun. 2024 (€-1.94 Mil) but then increased from Jun. 2024 (€-1.94 Mil) to Dec. 2024 (€1.35 Mil).

Maat Pharma's annual Other Operating Expense declined from Dec. 2022 (€-1.79 Mil) to Dec. 2023 (€-2.41 Mil) but then increased from Dec. 2023 (€-2.41 Mil) to Dec. 2024 (€-0.59 Mil).

Maat Pharma Other Operating Expense Historical Data

The historical data trend for Maat Pharma's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maat Pharma Other Operating Expense Chart

Maat Pharma Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

-1.54

-0.93

-1.79

-2.41

-0.59

Maat Pharma Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Operating Expense	Get a 7-Day Free Trial							-	-2.66	0.25	-1.94	1.35

Maat Pharma Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.59 Mil.

Maat Pharma Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Maat Pharma's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Maat Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Maat Pharma SA (XPAR:MAAT) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

4RD:Germany

Address

70 Avenue Tony Garnier, Lyon, FRA, 69007

Website

https://www.maatpharma.com

Maat Pharma SA is a french clinical stage biotech and a pioneer in the development of microbiome based ecosystem therapies dedicated to improving survival outcomes for patients with cancer.

Maat Pharma Headlines

No Headlines